C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.
about
Diagnosis and Management of Cardiovascular Disease in Advanced and End-Stage Renal DiseaseTransplant nephrectomy improves survival following a failed renal allograft.Effect of Vitamin C Supplementation on C-reactive Protein Levels in Patients Undergoing Hemodialysis: A Randomized, Double Blind, Placebo-Controlled Study.High-sensitivity C-reactive protein predicts mortality and technique failure in peritoneal dialysis patients.Circulating Inflammatory and Hemostatic Biomarkers are Associated with All-Cause Death and Cancer Death in a Population of Community-Dwelling Japanese: the Tanushimaru Study.The initial vascular access type contributes to inflammation in incident hemodialysis patients.The effect of high-flux hemodialysis on hemoglobin concentrations in patients with CKD: results of the MINOXIS studyAssociation of Processed Meat Intake with Hypertension Risk in Hemodialysis Patients: A Cross-Sectional Study.Environmental carbon monoxide level is associated with the level of high-sensitivity C-reactive protein in peritoneal dialysis patients.Levocarnitine and dialysis: a review.Inflammatory marker but not adipokine predicts mortality among long-term hemodialysis patients.Sevelamer for hyperphosphataemia in kidney failure: controversy and perspective.Inflammation and anaemia as predictors of cardiovascular mortality in hemodialysis patientsAssociation Between Hemodiafiltration and Hypoalbuminemia in Middle-Age Hemodialysis PatientsHypoalbuminaemia--a marker of cardiovascular disease in patients with chronic kidney disease stages II-IV.Association of a high normalized protein catabolic rate and low serum albumin level with carpal tunnel syndrome in hemodialysis patients.Serum Concentrations of F2-Isoprostanes and 4-Hydroxynonenal in Hemodialysis Patients in Relation to Inflammation and Renal AnemiaThe association between serum C-reactive protein and macronutrients and antioxidants intake in hemodialysis patients.Monitoring of inflammation in patients on dialysis: forewarned is forearmed.Vitamin d and stage 5 chronic kidney disease: a new paradigm?Management of cardiovascular disease in patients with kidney disease.Novel quercetin-3-O-glucoside eicosapentaenoic acid ester ameliorates inflammation and hyperlipidemia.Determinants of cardiovascular risk in haemodialysis patients: post hoc analyses of the AURORA study.Association of severity of conjunctival and corneal calcification with all-cause 1-year mortality in maintenance haemodialysis patients.Effect of resistance training during hemodialysis on circulating cytokines: a randomized controlled trial.Positive correlation of CRP and fibrinogen levels as cardiovascular risk factors in early stage of continuous ambulatory peritoneal dialysis patients.Serum CRP levels in pre-dialysis patients.Interleukin-6 is a better predictor of mortality as compared to C-reactive protein, homocysteine, pentosidine and advanced oxidation protein products in hemodialysis patients.The level of C-reactive protein in chronic hemodialysis patients: a comparative study between patients with noninfected catheters and arteriovenous fistula in two large Gulf hemodialysis centers.Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.The relationship between arteriovenous fistula success and inflammation.Pre-Dialysis Neutrophil-Lymphocyte Ratio, a Novel and Strong Short-Term Predictor of All-Cause Mortality in Patients With Diabetic Nephropathy: Results From a Single-Center Study.Anti-HLA sensitization after kidney allograft nephrectomy: changes one year post-surgery and beneficial effect of intravenous immunoglobulin.
P2860
Q26739024-C82EAACD-1BBE-47C2-A2E4-00B696FDD554Q33711231-BD524BBB-70BA-4B9E-A275-84028914B8EFQ34040520-7609BD45-9569-43CB-B543-A68EFC5A75FEQ35131398-C47FCC25-DB66-4157-8594-BF8E23FDDC2BQ35446081-AD5741B5-EE32-4E9D-B67A-72E247466EB6Q35450275-84F8CFB7-30EA-47C2-9387-A804DC3B2526Q35692440-0B2B50DB-3F46-4347-9BFB-8F2368D8F4A8Q35827489-2751581B-5135-4F03-91F7-7796714A3458Q36193835-D6BF8E54-41C5-4450-BFEA-5D0BB4F7C7F6Q36278353-4E5EFD26-C374-4347-8468-77D3A35C787AQ36417503-E5A73D1D-3378-4AB6-B850-D2A1FAC657ACQ36443804-4ADC18AA-E055-471D-B1CA-BE513246C9C5Q36765955-D46FD564-12E5-4E4F-AE9D-669E2DC45798Q36822422-62D841F3-AC9F-4191-B608-2361143E6A7DQ36973766-B6700EA6-F0C8-43DE-819B-4AB1D34F70F5Q37078064-DA3CEEF3-B688-41BD-B2A2-C5EE0FF70814Q37207365-8B6AAC17-9F39-43AC-994A-EC7D89D8D78CQ37668746-819CF0BC-F131-4333-81AA-9E79EE648AB0Q37848040-9B335E33-2DF6-464D-A0D2-C7DD09D59132Q37941837-B04C4CB0-4EB7-4E35-B128-6BCB8DFF11CCQ38082646-805ADBB2-0E01-4B90-967D-7B118E71D087Q38854091-2E2536E9-E157-4472-8F28-08402A8BA825Q44168285-C61DC215-55AB-48AF-94DD-3E18FC129F62Q45713465-1F664C2A-75AC-487E-89DB-2A99B7A3ECCFQ45779158-F5ABFF0C-E404-4B95-9BC6-1D2850F96F92Q46733484-E2AF128E-BF53-45E6-8557-217C454FCDB3Q46733498-3914E2ED-9EAF-4BF5-93FA-8A223B13E366Q46744891-576298E6-7C35-4956-8DEC-9E26C10222D4Q46821520-FA56A16D-597B-4FDF-A078-00FE89F01CDEQ47310363-4057E430-164E-4B41-80AB-A5F7D18EE9EBQ47883346-B2D5E810-40FA-47F6-AAD1-A176A722D30FQ50203698-8D1487BF-227A-4AEE-82D6-9FB5ADF8C768Q53108441-DCD2A995-1D67-45CD-B638-2128A3A77A40
P2860
C-reactive protein a marker for all-cause and cardiovascular mortality in haemodialysis patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@ast
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@en
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@nl
type
label
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@ast
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@en
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@nl
prefLabel
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@ast
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@en
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@nl
P356
P1476
C-reactive protein a marker fo ...... ity in haemodialysis patients.
@en
P2093
Christoph Wanner
Thomas Metzger
P304
29-32; discussion 39-40
P356
10.1093/NDT/17.SUPPL_8.29
P407
P478
17 Suppl 8
P577
2002-01-01T00:00:00Z